AEROLASE CORPORATION

Aerolase is a technology leader in laser skin health, specializing in the development and manufacturing of portable, high-power ultra-short pulse laser systems for medical and aesthetic dermatology. Based in Tarrytown, New York, the company leverages over 20 years of proprietary Microsecond Technology research to deliver safe and effective treatments across all Fitzpatrick skin types (I-VI) with minimal discomfort and downtime. The company's FDA-cleared portfolio includes the Neo Elite Laser (650-microsecond Nd:YAG), Era Elite (300-microsecond Er:YAG resurfacing), and V650 Laser systems, collectively addressing 30+ clinical indications including acne, rosacea, hyperpigmentation, melasma, vascular lesions, scars, hair removal, and photoaging. Aerolase's ultra-short pulse technology eliminates thermal damage and cooling requirements, enabling practitioners to treat 4-6 patients per hour while maintaining clinical consistency. The devices are trusted by leading dermatology programs at Stanford, UC Irvine, Jefferson Health, and Howard University, among others.